US equities |
SPCX $167.06 ▲+5.10% NVDA $237.18 ▲+1.38% MU $1,064.40 ▼-0.98% TSLA $377.55 ▲+1.88% MSFT $526.62 ▲+1.76% INTC $116.75 ▼-2.16% SNDK $1,714.19 ▼-0.34% META $745.53 ▲+2.40%
FinancialContent

Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

4.000 +0.100 (+2.56%)
Delayed Quote Updated: 11:19 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liminatus Pharma, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
From Liminatus Pharma Inc.
Via GlobeNewswire
News headline image
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
Engagement advances clinical execution of IBC101, Liminatus’ CD19xCD22 bivalent CAR-T therapy for relapsed or refractory B-cell malignancies 
From Liminatus Pharma Inc.
Via GlobeNewswire
News headline image
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
From Liminatus Pharma Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Thursday's session: most active stocks ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI)... 
Via Benzinga
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares increased... 
Via Benzinga
News headline image
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
From Liminatus Pharma Inc.
Via GlobeNewswire
What's going on in today's pre-market session ↗
Via Chartmill
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Curious about the most active stocks on Thursday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million. Agape ATP (NASDAQ:ATPC) shares moved... 
Via Benzinga
Thursday's session: top gainers and losers ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
Unusual volume stocks are being observed in Monday's session. ↗
Via Chartmill
News headline image
11 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million. Liminatus Pharma... 
Via Benzinga
Top movers in Thursday's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development... 
Via Benzinga
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
Transaction Expected to Close July 2, 2026 
From Liminatus Pharma Inc.
Via GlobeNewswire
Which stocks are moving on Wednesday? ↗
Via Chartmill
Here are the top movers in Wednesday's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 Next >